https://www.selleckchem.com/products/cadd522.html
40 patients were included in this analysis. 30-day-mortality rate was 25/40 (62.5%). Median overall survival of patients who survived the first 30days was 36 ± 18months. None of the analyzed factors was statistically significantly associated with 30-day mortality. Although mortality of patients with AMI due to acute arterial thrombosis remains high, almost 40% of patient who underwent emergent endovascular revascularization survived longer than one month. Since no predictors for the outcome in these patients were identified, all patient